Aroa Biosurgery hopes for sales boost after study finds high healing rates

Aroa Biosurgery hopes for sales boost after study finds high healing rates
Aroa founder Brian Ward says the largest study to date of its tissue repair products bodes well for the firm. (Image: Aroa Biosurgery)
Rebecca Stevenson
Aroa Biosurgery founder Brian Ward says a new large study proving the efficacy and cost saving of its tissue repair products should help to convince conservative surgeons to use them. In late December Australian Securities Exchange (ASX) listed Aroa announced a peer-reviewed study of 120 inpatients for two of its treatments, Myriad Matrix and Myriad Morcells, in lower limb reconstructions. The study, which was published in a plastic and reconstructive surgery journal in December, found one application of Myriad achieved tissue coverag...

More Markets

NZ stocks end firmly as outlook brightens
Markets Market Close

NZ stocks end firmly as outlook brightens

Improved, post-results season sentiment drove NZ stocks higher.

The Warehouse Albany and Silverdale could be first in line for store revamp
Retail

The Warehouse Albany and Silverdale could be first in line for store revamp

The Warehouse’s Albany and Silverdale stores could be first in line to undergo an interior revamp, according to chief executive Mark Stirton, who gave an update to shareholders at the company’s annual meeting on Friday.The meeting covered everything from the company’s 2025 financ...

Westpac cops $3.64m penalty for lender responsibility breaches
Finance

Westpac cops $3.64m penalty for lender responsibility breaches

Credit Contracts and Consumer Finance Act in focus again.

New Talisman in trading halt
Markets

New Talisman in trading halt

New Talisman Gold Mines has been placed in a trading halt because of its financial position.The mining company requested the halt, saying the board must meet “to consider the company’s current financial position and its strategic path forward”.“The board cannot reach a conclusion...